The Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.

There are only three liberal justices on the Supreme Court — and they are not on the same page. They are responding very ...

IBM’s new 120-qubit experiment marks a leap forward, advancing technology that could one day crack Bitcoin’s encryption.

A newly discovered protein from Earth's toughest animal is inspiring breakthrough therapies for cancer and cardiovascular ...

The Sramik-Karmachari Oikya Parishad (SKOP) is holding a mass hunger strike protesting the government’s decision to lease out ...

Joe Rogan was left stunned after Harvard astrophysicist Avi Loeb revealed discussions about alien tech tied to 3I/ATLAS are ...

The entorhinal/hippocampal circuit is known from past studies to be crucial for both memory formation and the recalling of ...

In September 2025, China's solar cell exports totalled 10.38GW, representing a 1.6% MoM decrease from August and a 6.2% YoY ...

Astrocytes have traditionally been thought to have a supporting role in the brain, but new research shows they also play a ...

The Kraft Heinz Company ( KHC) Q3 2025 Earnings Call October 28, 2025 8:00 PM EDT ...

Shipping and mailing solutions provider Pitney Bowes (NYSE:PBI) missed Wall Street’s revenue expectations in Q3 CY2025, with ...